Nodulocystic acne represents the most severe manifestation of acne vulgaris. Characterized by deep, painful, erythematous nodules measuring greater than 5mm in diameter, cystic acne poses a high risk of permanent atrophic and hypertrophic scarring without prompt medical intervention.
The Anatomy of Follicular Rupture
Cystic lesions originate when the infundibular wall of a plugged sebaceous follicle ruptures under pressure deep within the dermis. This releases keratin, sebum, lipid peroxides, and C. acnes antigens directly into surrounding connective tissue, eliciting an intense foreign-body immune reaction characterized by neutrophil infiltration and massive cytokine release (TNF-alpha, IL-1beta, IL-8).
Clinical Interventions
- Intralesional Corticosteroid Injections: Dilute triamcinolone acetonide (2.5–5 mg/mL) injected directly into acute cysts provides rapid anti-inflammatory relief within 24 to 48 hours, significantly reducing scar potential.
- Oral Isotretinoin: The only medication that induces long-term remission by shrinking sebaceous glands by over 90%, normalizing follicular keratinization, and halting bacterial colonization.
- Topical Anti-Inflammatory Support: Topical dapsone (5% or 7.5% gel) and azelaic acid (15% or 20%) offer non-steroidal anti-inflammatory benefit without disrupting the moisture barrier.